Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Bright Green appoints Seamus McAuley as CEO

Bright Green Corporation has appointed Chief Operating Officer (COO) Seamus McAuley as its new Chief Executive Officer (CEO). Mr. McAuley will succeed Terry Rafih, who will retain his role of Executive Chairman of the Board of Directors, after successfully leading and guiding Bright Green during a transformative time for the company. Bright Green’s executive management team, currently reporting to Mr. Rafih, will report to Mr. McAuley with immediate effect. The company has also begun the process of retaining a search firm to support the recruitment of key new executive roles.

Throughout his 26-year career, Mr. McAuley has held several global senior leadership positions across the pharmaceutical, medical device, and healthcare industries, including most recently as CEO of Alterola Biotech, a U.K.-based pharmaceutical company focused on developing cannabinoid and cannabinoid-like medicines and products. His broad and diverse experience informs his commitment to Bright Green’s strategy of botanical expertise, pharmaceutical development, and medical cannabinoid product supply.

Terry Rafih, executive chairman of the board of directors for Bright Green, said, “The Bright Green team and I are delighted to welcome Seamus to his new role as CEO. I am confident that, with his expertise in pharmaceuticals and product commercialization, he will successfully lead the execution of the next phase of Bright Green’s strategy. Seamus is uniquely positioned to advance the many opportunities that lie ahead for the company, including completing the buildout of and operating our agricultural complex in Grants, New Mexico. His drug development and commercialization expertise is timely and will be particularly relevant as we engage with the U.S. Food and Drug Administration (FDA) on the clinical development of a number of molecules, as well as navigate the various regulatory frameworks applicable to our business moving forward.”

Mr. McAuley, CEO of Bright Green, said, “I am honored to have the opportunity to lead Bright Green through the next phase of our development and help drive the revenue generation that will result from the successful execution of our strategy. We have planned carefully to further create shareholder value, and, pending approval and registration of our license with the U.S. Drug Enforcement Administration (DEA), Bright Green will be the only federally approved, publicly traded company focused on producing cannabis for the pharmaceutical industry in the U.S. With the development of our pharmaceutical assets, early engagement with the FDA and other global regulatory bodies, and the ability to supply both U.S. and global markets, I am excited about the potential of our portfolio and business, and look forward to sharing further updates in the weeks and months ahead.”

Lynn Stockwell, founder and board director of Bright Green, said, “The Board and I are thrilled to have Seamus serve as our new CEO. We have steadily built our business over the last several years, and we are confident that Seamus will successfully drive our strategy to become the premier federally authorized provider of cannabis and cannabis-derived products for the pharmaceutical industry. We are also incredibly grateful to Mr. Rafih for his work in getting Bright Green to this stage, and we are excited to have his continued support and guidance in his continued role as Executive Chairman of the Board.”

This news follows Bright Green’s announcement of its plans to raise $500 million under the United States Citizenship and Immigration Services (USCIS) EB-5 Program, an innovative vehicle for spurring investment and job creation in rural communities. USCIS administers the program, under which investors, their spouses, and unmarried children under 21 years of age are eligible to apply for a Green Card if they make the necessary investment in a commercial enterprise in the U.S. The company has already started to build its pipeline of potential investors, comprising both individual applicants, as well as large international companies with a global workforce. Bright Green is also delighted to confirm that it has received funds from its first applications, confirming the proof of concept for the EB-5 program following the recent announcement.

Further details on the Bright Green EB-5 program can be found by visiting our dedicated EB-5 website 

For more information:
Bright Green 

Publication date: